MicroRNA: a prognostic biomarker and a possible druggable target for circumventing multidrug resistance in cancer chemotherapy
about
Clinicopathological and prognostic implications of the miR-200 family in patients with epithelial ovarian cancer.Therapeutic Inhibition of miR-4260 Suppresses Colorectal Cancer via Targeting MCC and SMAD4.MicroRNA signatures as biomarkers and therapeutic target for CNS embryonal tumors: the pros and the cons.Tissue and Serum miRNA Profile in Locally Advanced Breast Cancer (LABC) in Response to Neo-Adjuvant Chemotherapy (NAC) Treatment.Differential expression of microRNAs in aortic tissue and plasma in patients with acute aortic dissection.Identification and Characterization of miRNAs in Response to Leishmania donovani Infection: Delineation of Their Roles in Macrophage DysfunctionRegulation of drug transporter expression and function in the placenta.MicroRNA-mRNA interactions in colorectal cancer and their role in tumor progression.MicroRNAs in inflammatory bowel diseases: paradoxes and possibilities.A novel miR-203-DNMT3b-ABCG2 regulatory pathway predisposing colorectal cancer development.Evidence for the role of microRNA 374b in acquired cisplatin resistance in pancreatic cancer cells.Perturbed microRNA Expression by Mycobacterium tuberculosis Promotes Macrophage Polarization Leading to Pro-survival Foam Cell.Increased Expression of a MicroRNA Correlates with Anthelmintic Resistance in Parasitic Nematodes.Possible Role of microRNA-122 in Modulating Multidrug Resistance of Hepatocellular Carcinoma.Long non-coding RNA CCAL regulates colorectal cancer progression by activating Wnt/β-catenin signalling pathway via suppression of activator protein 2α.MicroRNA-328 inhibits migration and epithelial-mesenchymal transition by targeting CD44 in nasopharyngeal carcinoma cells.MiRNA-150-3p targets SP1 and suppresses the growth of glioma cells.MicroRNA-495 Confers Increased Sensitivity to Chemotherapeutic Agents in Gastric Cancer via the Mammalian Target of Rapamycin (mTOR) Signaling Pathway by Interacting with Human Epidermal Growth Factor Receptor 2 (ERBB2)
P2860
Q33802682-3411BAC8-3BD1-45FE-A4B7-8BC4D6C9D143Q33821005-F9BB5677-3F87-4AB8-8C7C-97BEA30DD6F6Q34685896-95F766AE-62A7-4C59-8A01-90B543BC8EEEQ35985784-9C2D08C3-5EFD-4887-A80E-7D213F662EE5Q36460937-C8050747-E7F3-4E02-BF9A-D3F1D8319D94Q37675397-B7A1D37F-14A3-4D73-AA0F-ED5E12108E41Q38323562-BF2B4476-F7A8-48B0-AF58-FE57BF118FBDQ38331867-BFF99CF3-018A-418F-A016-6B35BB29737DQ38407040-3754421B-8B68-49B7-8F71-58CF75A38230Q38767018-1CA7A629-D471-4564-893C-CBF5B1A900C0Q38768272-20C97CEB-5A51-429D-8131-A0D06524CE03Q42323372-5ED8E97D-65A5-4B4D-B607-711FE4D82D78Q46247203-B480058F-596F-4901-8026-508A52665112Q49679382-6E74F226-1BA2-4F5B-B34F-DCDD8A48F662Q53219055-A5028F34-CBDF-4FC7-8387-3B9B5C65B2C6Q55394876-80647EE6-BAEF-4167-B826-3C390785ABF8Q55457308-C4F49A44-BCCB-4648-A580-571291ECDB3FQ58700608-4C252AC8-0ACB-4D73-8FFE-C2A937113982
P2860
MicroRNA: a prognostic biomarker and a possible druggable target for circumventing multidrug resistance in cancer chemotherapy
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
MicroRNA: a prognostic biomark ...... istance in cancer chemotherapy
@en
type
label
MicroRNA: a prognostic biomark ...... istance in cancer chemotherapy
@en
prefLabel
MicroRNA: a prognostic biomark ...... istance in cancer chemotherapy
@en
P2860
P921
P356
P1476
MicroRNA: a prognostic biomark ...... istance in cancer chemotherapy
@en
P2093
Kenneth K W To
P2860
P2888
P356
10.1186/1423-0127-20-99
P5008
P577
2013-12-20T00:00:00Z
P5875
P6179
1032507818